4DMT’s 4D-150 Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

2025-05-02|

4DMT’s 4D-150 Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation

by Mark Chiang

Share To

4D Molecular Therapeutics (4DMT) announced that the Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to their product 4D-150. The FDA granted this designation to 4DMT for their product 4D-150. The RMAT designation is for 4D-150, which is under development by 4DMT. The FDA uses the RMAT designation to expedite the development and review of regenerative medicine therapies.

Newsflash | Powered by GeneOnline AI
Date: May 2, 2025

Author

Mark Chiang

Region

A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech

2025-05-21

LATEST

A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech

2025-05-21

ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval

2025-05-20

NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts

2025-05-20

Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO

2025-05-20

UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates

2025-05-20

Trump Science Adviser Michael Kratsios Calls for Renewed Focus on Reproducible Research Practices to Address Scientific Stagnation

2025-05-20

House Republicans Propose $700 Billion Medicaid Savings with Work Requirements

2025-05-20

EVENT

2025-05-26

2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference

Taipei, Taiwan

2025-05-30

ASCO Annual Meeting 2025

Chicago, U.S.A

2025-06-11

ISSCR 2025 Annual Meeting

Hong Kong

2025-06-16

US BIO International Convention

Boston, U.S.A.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

GENE ONLINE|News &
Opinion
Blog